- Home
- ICCC vs OVID Comparison
ICCC vs OVID Comparison
Compare ICCC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- OVID
- Stock Information
- Founded
- ICCC 1982
- OVID 2014
- Country
- ICCC United States
- OVID United States
- Employees
- ICCC N/A
- OVID N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- ICCC Health Care
- OVID Health Care
- Exchange
- ICCC Nasdaq
- OVID Nasdaq
- Market Cap
- ICCC 45.9M
- OVID 49.6M
- IPO Year
- ICCC 1987
- OVID 2017
- Fundamental
- Price
- ICCC $5.11
- OVID $0.70
- Analyst Decision
- ICCC
- OVID Strong Buy
- Analyst Count
- ICCC 0
- OVID 5
- Target Price
- ICCC N/A
- OVID $4.04
- AVG Volume (30 Days)
- ICCC 10.1K
- OVID 376.5K
- Earning Date
- ICCC 02-25-2025
- OVID 03-07-2025
- Dividend Yield
- ICCC N/A
- OVID N/A
- EPS Growth
- ICCC N/A
- OVID N/A
- EPS
- ICCC N/A
- OVID N/A
- Revenue
- ICCC $23,838,001.00
- OVID $631,695.00
- Revenue This Year
- ICCC N/A
- OVID $71.71
- Revenue Next Year
- ICCC N/A
- OVID $741.55
- P/E Ratio
- ICCC N/A
- OVID N/A
- Revenue Growth
- ICCC 46.37
- OVID 113.21
- 52 Week Low
- ICCC $3.34
- OVID $0.68
- 52 Week High
- ICCC $5.82
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- ICCC 52.70
- OVID 23.73
- Support Level
- ICCC $4.86
- OVID $0.75
- Resistance Level
- ICCC $5.50
- OVID $0.79
- Average True Range (ATR)
- ICCC 0.36
- OVID 0.07
- MACD
- ICCC -0.03
- OVID -0.02
- Stochastic Oscillator
- ICCC 39.06
- OVID 4.08
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.